Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Flurbiprofen in dysmenorrhea

J E DeLia, M G Emery, R H Taylor

    Clinical Pharmacology and Therapeutics
    |July 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Flurbiprofen effectively relieved pain and improved daily function for patients with dysmenorrhea, outperforming aspirin and placebo. While minor side effects occurred, flurbiprofen demonstrated significant therapeutic utility.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Predictors of interferon-gamma release assay results and their association with COVID-19 infection outcomes.

    IJTLD open·2024
    Same author

    Correction to: Characterization of host response, resorption, and strength properties, and performance in the presence of bacteria for fully absorbable biomaterials for soft tissue repair.

    Hernia : the journal of hernias and abdominal wall surgery·2024
    Same author

    Optogenetic stimulation of striatal patches modifies habit formation and inhibits dopamine release.

    Scientific reports·2021
    Same author

    What are the immunological and clinical implications of microchimerism?

    BJOG : an international journal of obstetrics and gynaecology·2018
    Same author

    Safety of eliminating postpartum magnesium sulphate: intriguing but not yet proven.

    BJOG : an international journal of obstetrics and gynaecology·2018
    Same author

    Characterization of host response, resorption, and strength properties, and performance in the presence of bacteria for fully absorbable biomaterials for soft tissue repair.

    Hernia : the journal of hernias and abdominal wall surgery·2017
    Same journal

    The Future of Clinical Pharmacology: The Right Medicine at the Right Dose for Each Patient.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Effects of Trimethoprim on Three Previously Proposed Putative Biomarkers for OCT2/MATE-Mediated Renal Drug-Drug Interactions in Healthy Volunteers.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Clinical Characterization of Enzyme and Transporter Precipitants to Evaluate Drug-Drug Interactions for Orforglipron, a Small Molecule Glucagon-Like Peptide-1 Receptor Agonist.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Symposium Report: Stakeholders' Perspectives on Phase 1 Trials in Japanese Prior to Multi-Regional Clinical Trials and Future Pathways.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Resolving CYP2D6 Structural Complexity with Long-Read Sequencing: Implications for Tamoxifen Precision Dosing in Thai Breast Cancer Patients.

    Clinical pharmacology and therapeutics·2026
    Same journal

    Identification of a Functional CYP2C8 Variant Allele that Alters Splicing, Reduces Protein Expression, and Increases Drug Exposure.

    Clinical pharmacology and therapeutics·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Gastroenterology
    • Women's Health

    Background:

    • Dysmenorrhea, or painful menstruation, significantly impacts women's quality of life.
    • Current treatments for dysmenorrhea have varying efficacy and side effect profiles.
    • Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used, but comparative efficacy data can be conflicting.

    Purpose of the Study:

    • To compare the efficacy of flurbiprofen, aspirin, and placebo in managing dysmenorrhea.
    • To assess patient preference and the impact on daily function.
    • To evaluate the reduction in the need for additional analgesics.

    Main Methods:

    • A randomized controlled trial involving 59 patients with dysmenorrhea.
    • Administration of flurbiprofen (50 mg), aspirin (650 mg), or placebo.

    Related Experiment Videos

  • Paired drug comparisons to evaluate patient-reported outcomes.

    • Main Results:

    • Patients significantly preferred flurbiprofen over aspirin and placebo.
    • Flurbiprofen demonstrated superior efficacy in pain relief and maintaining daily function.
    • Flurbiprofen use led to a reduced need for supplementary pain medication.
    • Aspirin showed only marginal improvement over placebo, except in patient preference.
    • Minor side effects were more frequent in the flurbiprofen group.

    Conclusions:

    • Flurbiprofen is a therapeutically useful option for managing dysmenorrhea.
    • Flurbiprofen offers superior pain relief and functional improvement compared to aspirin and placebo.
    • Despite a slight increase in minor side effects, flurbiprofen's benefits outweigh the risks for dysmenorrhea treatment.